These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25548529)

  • 1. Multiple system atrophy: genetic or epigenetic?
    Sturm E; Stefanova N
    Exp Neurobiol; 2014 Dec; 23(4):277-91. PubMed ID: 25548529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
    Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
    Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models of multiple system atrophy.
    Fellner L; Wenning GK; Stefanova N
    Curr Top Behav Neurosci; 2015; 22():369-93. PubMed ID: 24338664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
    Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
    Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update.
    Jellinger KA; Lantos PL
    Acta Neuropathol; 2010 Jun; 119(6):657-67. PubMed ID: 20309568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy.
    Bettencourt C; Foti SC; Miki Y; Botia J; Chatterjee A; Warner TT; Revesz T; Lashley T; Balazs R; Viré E; Holton JL
    Acta Neuropathol; 2020 Jan; 139(1):135-156. PubMed ID: 31535203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
    Jellinger KA
    Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation.
    Sekiya H; Kowa H; Koga H; Takata M; Satake W; Futamura N; Funakawa I; Jinnai K; Takahashi M; Kondo T; Ueno Y; Kanagawa M; Kobayashi K; Toda T
    Acta Neuropathol; 2019 Mar; 137(3):455-466. PubMed ID: 30721406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple system atrophy: the application of genetics in understanding etiology.
    Federoff M; Schottlaender LV; Houlden H; Singleton A
    Clin Auton Res; 2015 Feb; 25(1):19-36. PubMed ID: 25687905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
    Krejciova Z; Carlson GA; Giles K; Prusiner SB
    Acta Neuropathol Commun; 2019 May; 7(1):81. PubMed ID: 31109379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple system atrophy: alpha-synuclein and neuronal degeneration.
    Yoshida M
    Neuropathology; 2007 Oct; 27(5):484-93. PubMed ID: 18018485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy.
    Pountney DL; Dickson TC; Power JH; Vickers JC; West AJ; Gai WP
    Neurotox Res; 2011 Jan; 19(1):115-22. PubMed ID: 20039155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy.
    Jin H; Ishikawa K; Tsunemi T; Ishiguro T; Amino T; Mizusawa H
    J Med Dent Sci; 2008 Mar; 55(1):145-53. PubMed ID: 19845160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
    Wakabayashi K; Yoshimoto M; Tsuji S; Takahashi H
    Neurosci Lett; 1998 Jun; 249(2-3):180-2. PubMed ID: 9682846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy: genetic risks and alpha-synuclein mutations.
    Whittaker HT; Qui Y; Bettencourt C; Houlden H
    F1000Res; 2017; 6():2072. PubMed ID: 29225795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alpha-synuclein in the pathogenesis of multiple system atrophy.
    Wenning GK; Jellinger KA
    Acta Neuropathol; 2005 Feb; 109(2):129-40. PubMed ID: 15666181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Synuclein Inclusion Formation in Human Oligodendrocytes.
    Yoon YS; Ahn WJ; Ricarte D; Ortiz D; Shin CY; Lee SJ; Lee HJ
    Biomol Ther (Seoul); 2021 Jan; 29(1):83-89. PubMed ID: 32536617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.